Wyeth Korea to launch Enbrel, generically engineered protein

Wyeth Korea unveiled a plan to launch Enbrel (etanercept), a genetically engineered protein, in Korea at the end of this month.

Enbrel binds to tumor necrosis factor (TNF), a naturally occurring protein in the body, and inhibits its action. Unlike the existing palliative therapies, Enbrel serves to alleviate mild to severe symptoms associated with rheumatoid arthritis and prevent the progres...